IPCALAB.NS
Ipca Laboratories Limited$1,641.90
Jun 05, 2026
Market cap
$416.56B
52w range
—
P / E
—
EPS · FY 2026
$44.98
Volume
—
Revenue · FY 2026
$96.46B
Explain this page
Arphra AIPlain-English read on Ipca Laboratories Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$986.74
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-1.69%
- Solar-6.96%
- REIT - Healthcare Facilities-3.27%
- Construction Materials-3.10%
- Copper-3.02%
- Biotechnology-2.86%
- Medical - Healthcare Information Services-2.58%
- Financial - Mortgages-2.51%
- Software - Infrastructure-2.48%
- Security & Protection Services-2.31%
- Electrical Equipment & Parts-2.27%
- REIT - Specialty-2.22%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for IPCALAB.NS.
Peers
No peer list available for IPCALAB.NS.
Total assets
$123.7B
Total debt
$8.09B
Cash & equiv
$5.65B
Operating CF
$11.42B
Free cash flow
$4.86B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $96.46B | $23.32B | $11.41B | $44.98 | +11.83% |